NSETrading Window28 Sept 2026 · 28 Sept 2026, 10:57 am
Trading Window
Aarti Pharmalabs Limited · AARTIPHARM
✦ AI SummaryRegulatory
Aarti Pharmalabs Limited has informed the Exchange regarding the closure of the trading window due to SEBI (Prohibition of Insider Trading) Regulations, 2015, effective from October 1, 2026, until 48 hours after the declaration of financial results for the quarter ending September 30, 2026.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk8/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Aarti Pharmalabs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
AARTIPHARMA_28092026105725_APL_Window_Closure_September_2026signed.pdf
View document text
September 28, 2026
To, To,
Listing/ Compliance Department Listing/ Compliance Department
BSE LTD. National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers, “Exchange Plaza”, Plot No. C/1,
Dalal Street, G Block, Bandra Kurla Complex,
Mumbai - 400 001 Bandra (E), Mumbai – 400 051
SCRIP CODE: 543748 SYMBOL: AARTIPHARM
Dear Sir/Madam,
Sub: Closure of Trading Window
Ref: SEBI (Prohibition of Insider Trading)
Regulations, 2015
Pursuant to Company’s Code Prohibition of Insider Trading framed pursuant to Securities and
Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and amendments
thereunder, the trading window for dealing in the securities of the Company will remain closed
from Thursday, October 01, 2026 till 48 hours after the declaration of Financial Results of the
Company for the quarter ending on September 30, 2026. The same has also been intimated to
all the Designated Persons/Connected Persons of the Company.
The date of the Board Meeting in which the said results will be considered for approval, will be
informed in due course.
Please take note of the above on your record.
Thanking you,
Yours faithfully,
For AARTI PHARMALABS LIMITED
JEEVAN MONDKAR
COMPANY SECRETARY AND LEGAL HEAD
ICSI M. NO. A22565